Cargando…
An effective platform for cancer immunotherapy: pooled knockin targeting for genome engineering
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293244/ https://www.ncbi.nlm.nih.gov/pubmed/32532958 http://dx.doi.org/10.1038/s41392-020-0208-9 |
_version_ | 1783546260581515264 |
---|---|
author | Jin, Ke Zhang, Long Zhou, Fangfang |
author_facet | Jin, Ke Zhang, Long Zhou, Fangfang |
author_sort | Jin, Ke |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7293244 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-72932442020-06-19 An effective platform for cancer immunotherapy: pooled knockin targeting for genome engineering Jin, Ke Zhang, Long Zhou, Fangfang Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2020-06-12 /pmc/articles/PMC7293244/ /pubmed/32532958 http://dx.doi.org/10.1038/s41392-020-0208-9 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Highlight Jin, Ke Zhang, Long Zhou, Fangfang An effective platform for cancer immunotherapy: pooled knockin targeting for genome engineering |
title | An effective platform for cancer immunotherapy: pooled knockin targeting for genome engineering |
title_full | An effective platform for cancer immunotherapy: pooled knockin targeting for genome engineering |
title_fullStr | An effective platform for cancer immunotherapy: pooled knockin targeting for genome engineering |
title_full_unstemmed | An effective platform for cancer immunotherapy: pooled knockin targeting for genome engineering |
title_short | An effective platform for cancer immunotherapy: pooled knockin targeting for genome engineering |
title_sort | effective platform for cancer immunotherapy: pooled knockin targeting for genome engineering |
topic | Research Highlight |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293244/ https://www.ncbi.nlm.nih.gov/pubmed/32532958 http://dx.doi.org/10.1038/s41392-020-0208-9 |
work_keys_str_mv | AT jinke aneffectiveplatformforcancerimmunotherapypooledknockintargetingforgenomeengineering AT zhanglong aneffectiveplatformforcancerimmunotherapypooledknockintargetingforgenomeengineering AT zhoufangfang aneffectiveplatformforcancerimmunotherapypooledknockintargetingforgenomeengineering AT jinke effectiveplatformforcancerimmunotherapypooledknockintargetingforgenomeengineering AT zhanglong effectiveplatformforcancerimmunotherapypooledknockintargetingforgenomeengineering AT zhoufangfang effectiveplatformforcancerimmunotherapypooledknockintargetingforgenomeengineering |